MENU
CLVLF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Clinuvel Pharmaceuticals (CLVLF) Ownership - Who owns Clinuvel Pharmaceuticals?
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria... Show more
Profile
Industry
N/A
Address
535 Bourke Street
Phone
+61 396604900
Employees
16
Web
https://www.clinuvel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
396M
P/E Ratio
16.66
Total Cash
224.11M
Projected Growth
N/A
Total Debt
528.53K
Revenue
95.02M
Risk (Beta)
0.48
Dividend Yield
0.00
Total Cash/Share
4.47
Total Debt/Equity
N/A
Revenue/Share
1.26 USD as % of share price
Fundamentals
CLVLF
Capitalization
396M
P/E Ratio
16.66
Risk (Beta)
0.48
Dividend Yield
0.00
Total Cash
224M
Total Cash/Share
4.47
Total Debt
529K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.26%
Revenue
95M
ROE
N/A
Book Value
241M
P/B Ratio
2.49
Cash Flow
N/A
Earnings
0.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
169M
Current Ratio
9.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
57.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
14.39
Shares Held By Institutions
57.5M
Shares Outstanding - Current
50.1M
Total Liabilities
30.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-5.562
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
535 Bourke Street
Phone
+61 396604900
Employees
16
Web
https://www.clinuvel.com